Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)

Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)

The use of noninsulin antihyperglycaemic drugs in the hospital setting has not yet been fully described. This observational study compared the efficacy and safety of the standard basal-bolus insulin regimen versus a dipeptidyl peptidase-4 inhibitor (linagliptin) plus basal insulin in medicine depart...

Full description

Bibliographic Details
Main Authors: Luis M. Pérez-Belmonte, Juan J. Gómez-Doblas, Mercedes Millán-Gómez, María D. López-Carmona, Ricardo Guijarro-Merino, Fernando Carrasco-Chinchilla, Eduardo de Teresa-Galván, Manuel Jiménez-Navarro, M. Rosa Bernal-López, Ricardo Gómez-Huelgas
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Journal of Clinical Medicine
Subjects:
diabetes mellitus
linagliptin
inpatient hyperglycaemia
hospital care
Online Access:http://www.mdpi.com/2077-0383/7/9/271

Internet

http://www.mdpi.com/2077-0383/7/9/271

Similar Items